Is surgery required for melasma?

  Melasma generally does not require conventional surgical treatment, as it is a pigmentary disorder resulting from abnormal melanin metabolism—not an organic pathological condition. Since no structural tissue abnormalities are present, surgery cannot eradicate the condition. Clinical management primarily focuses on conservative regulation and photonic therapies. If melasma spreads extensively or darkens progressively, prompt medical consultation and standardized treatment are essential.

  Melasma commonly arises from endocrine fluctuations, ultraviolet (UV) radiation exposure, and irregular sleep-wake cycles. Its core pathophysiology involves disordered distribution and accumulation of melanin in both the epidermis and dermis. Conventional surgical interventions cannot selectively target diffusely distributed pigment granules; moreover, they risk damaging healthy skin tissue, potentially leading to complications such as scarring or post-inflammatory hyperpigmentation. In most mild cases, melasma gradually fades with appropriate skincare regimens and topical medications.

  Clinically, minimally invasive photonic therapies and pharmacological regulation constitute the mainstay of intervention. For superficial melasma, consistent use of topical depigmenting agents helps normalize melanin metabolism. For deeper, more refractory lesions, laser-based photonic treatments can fragment melanin aggregates, while systemic approaches—such as hormonal modulation—help stabilize endocrine function. A comprehensive, multimodal strategy effectively lightens pigmentation and reduces recurrence risk, meeting the therapeutic needs of the vast majority of melasma patients.

  Daily lifestyle measures—including maintaining emotional stability and regular sleep patterns, avoiding prolonged sun exposure, and consuming vitamin-rich foods—support endocrine balance and healthy skin metabolism, thereby minimizing abnormal melanin deposition and helping sustain facial skin health.